fashion -WSS

fashion

author：explore 2025-09-28 13:23:36 - browse：5678

A heart monitoring watch, referred as Project Zero 2.0 is displayed in the Omron Healthcare booth during a press event – health tech coverage from STAT — Digital tools to better track blood pressure over time and encourage adherence to treatment plans are increasingly commonplace. David Becker/Getty Images

If you have high blood pressure, it’s increasingly likely that your doctor or your insurer will offer you a blood pressure cuff or an educational app to help you get it under control. While potentially impactful, these tools may not be reaching marginalized people who don’t regularly have access to good health care — and who may benefit the most from the tools.

A new analysis suggests that there ought to be more investment in novel hypertension programs for people experiencing health disparities.The meta-review of 28 studies of digital health interventions for people of color and low-income patients found that as a whole participants saw a statistically significant and clinically meaningful reduction in average systolic blood pressure compared to control groups. In total, the analysis included more than 8,000 participants; most of the studies followed participants for six or 12 months. The results, published Wednesday in JAMA Network Open, are consistent with studies of digital tools in the general population.

Joseph Ebinger, of the Smidt Heart Institute at Cedars-Sinai in Los Angeles, who was not involved in the study, said it provides needed evidence that “there are tools that exist to be able to help meet individuals where they are in the world, and they should be utilized more heavily.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

WSS

Achieving telehealth equity for people with hearing loss

The Bio Revolution is changing business and society

Histogen: Failed biotech offers rare public look inside

Why some fertility treatments produce more boy babies

Why age limits for politicians are a terrible idea

What to expect at HLTH 2023, the health care industry conference

leisure time

fashion

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

Analysis of telehealth claims data suggest service duplication

Walensky prepares to leave CDC — and Congress — behind

Unmasking the 'centricity' illusion in clinical trials

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Pharma’s losing bet in New Jersey

How one medical school became remarkably diverse

Hospitals need to get ahead of regulations on climate change

Medical records are filled with copy

The future of health care in the House

leisure time

Some medical students still think black patients feel less pain

VC firm General Catalyst wants to buy a health system

Should insurance cover cosmetic surgery?

J&J reports mixed data on next

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

FDA authorizes Novavax’s updated Covid

focus

leisure time

hotspot

Wikipedia